Edap Tms S.A. (NASDAQ:EDAP) Short Interest Update

Edap Tms S.A. (NASDAQ:EDAP) saw a large decline in short interest in the month of January. As of January 30th, there was short interest totaling 75,567 shares, a decline of 20.6% from the January 15th total of 95,120 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily trading volume, of 82,208 shares, the days-to-cover ratio is presently 0.9 days. Based on an average daily trading volume, of 82,208 shares, the days-to-cover ratio is presently 0.9 days. Currently, 0.2% of the shares of the company are short sold.

Edap Tms Price Performance

NASDAQ EDAP traded down $0.10 during mid-day trading on Friday, hitting $4.67. The stock had a trading volume of 64,178 shares, compared to its average volume of 90,229. The company has a 50 day simple moving average of $3.65 and a 200 day simple moving average of $2.64. The company has a market cap of $174.61 million, a price-to-earnings ratio of -8.19 and a beta of -0.16. Edap Tms has a 52-week low of $1.21 and a 52-week high of $5.05. The company has a quick ratio of 0.97, a current ratio of 1.41 and a debt-to-equity ratio of 0.04.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the stock. Jefferies Financial Group reaffirmed a “hold” rating and issued a $2.00 target price on shares of Edap Tms in a report on Thursday, November 6th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Edap Tms in a report on Monday, December 29th. Finally, Wall Street Zen raised Edap Tms to a “hold” rating in a research note on Saturday, February 7th. One investment analyst has rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $8.50.

Institutional Investors Weigh In On Edap Tms

Several institutional investors and hedge funds have recently made changes to their positions in the business. Financial Planning Navigators CORP acquired a new stake in Edap Tms in the 4th quarter valued at about $33,000. Kovack Advisors Inc. purchased a new stake in shares of Edap Tms in the fourth quarter valued at about $53,000. Leonteq Securities AG purchased a new stake in shares of Edap Tms in the fourth quarter valued at about $313,000. Finally, Sage Mountain Advisors LLC acquired a new stake in shares of Edap Tms in the second quarter valued at approximately $165,000. 62.74% of the stock is currently owned by hedge funds and other institutional investors.

About Edap Tms

Edap Tms SA (NASDAQ: EDAP) is a Lyon, France–based medical device company that develops and markets noninvasive therapeutic systems for urological applications. The firm’s core focus lies in high-intensity focused ultrasound (HIFU) for localized prostate tissue ablation and extracorporeal shock-wave lithotripsy for kidney stone fragmentation. Edap Tms’s Ablatherm HIFU platform delivers targeted ultrasound energy to treat prostate cancer without incisions, while its Sonolith line offers pulse-focused shock waves designed to break down urinary calculi.

Since its founding in 1989, Edap Tms has pursued regulatory clearances in multiple markets, including CE marking in Europe and FDA clearance for its HIFU system in the United States.